AI assistant
Vanda Pharmaceuticals Inc. — Director's Dealing 2009
Nov 10, 2009
33390_dirs_2009-11-10_df35aef0-56f7-4deb-9622-2e1cff23d25d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Vanda Pharmaceuticals Inc. (VNDA)
CIK: 0001347178
Period of Report: 2009-11-06
Reporting Person: Feeney John Joseph (Acting Chief Medical Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2009-11-06 | Common Stock | M | 9583 | $8.73 | Acquired | 9583 | Direct |
| 2009-11-06 | Common Stock | M | 572 | $5.76 | Acquired | 10155 | Direct |
| 2009-11-06 | Common Stock | M | 4062 | $1.02 | Acquired | 14217 | Direct |
| 2009-11-06 | Common Stock | S | 14217 | $10.3263 | Disposed | 0 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2009-11-06 | Employee Stock Option (right to buy) | $8.73 | M | 9583 | Disposed | 2017-11-28 | Common Stock (9583) | Direct |
| 2009-11-06 | Employee Stock Option (right to buy) | $5.76 | M | 572 | Disposed | 2018-01-03 | Common Stock (572) | Direct |
| 2009-11-06 | Employee Stock Option (right to buy) | $1.02 | M | 4062 | Disposed | 2018-09-18 | Common Stock (4062) | Direct |
Footnotes
F1: This transaction was executed in multiple trades at prices ranging from $10.26 to $10.40. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2: The option represents a right to purchase a total of 20,000 shares. 25% of the shares subject to the option became exercisable on November 14, 2008 with the remaining shares becoming exercisable in 36 equal monthly installments thereafter.
F3: The option represents a right to purchase a total of 1,250 shares. The option vests in 48 equal monthly installments beginning on February 4, 2008.
F4: The option represents a right to purchase a total of 15,000 shares. 25% of the shares subject to the option became exercisable on September 19, 2009 with the remaining shares becoming exercisable in 36 equal monthly installments thereafter.